Terms: = Kidney tumors AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769
8 results:
1. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
Jiang Z; Wang H; Wang S; Guan C; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
[TBL] [Abstract] [Full Text] [Related]
2. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
Yang X; Mei C; Nie H; Zhou J; Ou C; He X
Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
[TBL] [Abstract] [Full Text] [Related]
3. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
4. Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: A meta-analysis.
Fang J; Xu X; Mao Q; Ying Y; Zhang X; Xie L
Int J Biol Markers; 2020 Mar; 35(1):57-64. PubMed ID: 31973613
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.
Das R; Gregory PA; Fernandes RC; Denis I; Wang Q; Townley SL; Zhao SG; Hanson AR; Pickering MA; Armstrong HK; Lokman NA; Ebrahimie E; Davicioni E; Jenkins RB; Karnes RJ; Ross AE; Den RB; Klein EA; Chi KN; Ramshaw HS; Williams ED; Zoubeidi A; Goodall GJ; Feng FY; Butler LM; Tilley WD; Selth LA
Cancer Res; 2017 Feb; 77(4):1021-1034. PubMed ID: 28011622
[TBL] [Abstract] [Full Text] [Related]
6. Decreased mRNA expression of GATA1 and gata2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.
Peters I; Dubrowinskaja N; Tezval H; Kramer MW; von Klot CA; Hennenlotter J; Stenzl A; Scherer R; Kuczyk MA; Serth J
Target Oncol; 2015 Jun; 10(2):267-75. PubMed ID: 25230694
[TBL] [Abstract] [Full Text] [Related]
7. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract] [Full Text] [Related]
8. Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Bacoyiannis C; Dimopoulos MA; Kalofonos HP; Nicolaides C; Aravantinos G; Bafaloukos D; Samelis G; Onyenadum A; Kiamouris Ch; Skarlos D; Pavlidis N; Triantafillidis A; Kosmidis P;
Oncology; 2002; 63(2):130-8. PubMed ID: 12239447
[TBL] [Abstract] [Full Text] [Related]
